Abstract:ABSTRACT During April 2009, a novel H1N1 influenza A virus strain was identified in Mexico and the USA. Within weeks the virus had spread globally and the first pandemic of the 21st Century had been declared. It is unlikely to be the last and it is crucial that real lessons are learned from the experience. Asia is considered a hot spot for the emergence of new pathogens including past influenza pandemics. On this occasion while preparing for an avian, highly virulent influenza virus (H5N1 like) originating in Asia in fact the pandemic originated from swine, and was less virulent. This discrepancy between what was planned for and what emerged created its own challenges. The H1N1 pandemic has tested national health‐care infrastructures and exposed shortcomings in our preparedness as a region. Key health challenges include communication throughout the region, surge capacity, access to reliable information and access to quality care, health‐care worker skills, quality, density and distribution, access to essential medicines and lack of organizational infrastructure for emergency response. Despite years of preparation the public health and clinical research community were not ready to respond and opportunities for an immediate research response were missed. Despite warm words and pledges efforts to engage the international community to ensure equitable sharing of limited resources such as antivirals and vaccines fell short and stockpiles in the main remained in the rich world. This manuscript with authors from across the region describes some of the major challenges faced by Asia in response to the pandemic and draws lessons for the future.

Progress on 2009 H1N1 Virus and Prevention and Treatment of Influenza Pandemic

Research Advances in Human Infection with Avian-Origin Influenza A (H7n9)virus

Research Progress on Drug-Resistance of Influenza Virus to Neuraminidase Inhibitors

Research progress on human infection with avian influenza H7N9

Progress of Influenza Viruses and Inhibitors

Progress Of Small Molecular Inhibitors In The Development Of Anti-Influenza Virus Agents

Research Progress of Influenza A H1N1 Virus in 2009

Study on the Genomic Sequences and Molecular Characteristics of Influenza A(H1N1) Virus

Targets for Anti-Influenza Virus Agents: Research Advances

History and Reflection of Pandemic Influenza

The Development History, Structural Composition, and Functions of Influenza Viruses and the Progress of Influenza Virus Inhibitors in Clinics and Clinical Trials

[Current situation of A/H1N1 influenza in the world]

Deep analysis of influenza epidemic in China in this year

Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates

Continuing challenges in influenza

Pandemic Response Lessons from Influenza H1N1 2009 in Asia

Pandemic response lessons from influenza H1N1 2009 in Asia.

Therapy of severe cases of pandemic influenza A(H1N1) 2009

Natural Product-Derived Phytochemicals for Influenza A Virus (H1N1) Prevention and Treatment

Evaluation of containment and mitigation strategies for an influenza A pandemic in China

Research Progress of Severe Influenza A H1N1